Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma (pages 2214–2223)
Vassiliki A. Papadimitrakopoulou, Lawrence E. Ginsberg, Adam S. Garden, Merrill S. Kies, Bonnie S. Glisson, Eduardo M. Diaz Jr., Gary Clayman, William H. Morrison, Diane D. Liu, George Blumenschein Jr., Scott M. Lippman, Donald Schommer, Ann Gillenwater, Helmuth Goepfert and Waun K. Hong
Article first published online: 29 SEP 2003 | DOI: 10.1002/cncr.11771
Intraarterial cisplatin combined with intravenous paclitaxel and ifosfamide was studied as an organ-preservation approach for patients with paranasal sinus carcinoma. Although the orbit preservation rate was high (88%), central nervous system toxicity was substantial.